Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on October 25, 2024, primarily to furnish its third-quarter 2024 earnings press release. While the 8-K itself does not contain detailed financial figures from the press release, it signals the company's official communication of its operational and financial results for the period ending September 30, 2024. Investors should refer to the accompanying press release (Exhibit 99.1) for specific revenue, profit, and operational metrics. In addition to the financial results announcement, HCA's Board of Directors declared a quarterly cash dividend of $0.66 per share. This dividend is payable on December 27, 2024, to shareholders of record as of December 13, 2024. This action indicates continued capital return to shareholders and should be considered by income-focused investors.
Key Highlights
- 1HCA Healthcare announced its third-quarter 2024 financial results on October 25, 2024, via an 8-K filing.
- 2The primary purpose of the 8-K is to provide the company's earnings press release, which contains detailed Q3 2024 operational and financial performance.
- 3Investors are directed to Exhibit 99.1 of the 8-K filing for specific Q3 earnings data.
- 4HCA's Board of Directors declared a quarterly cash dividend of $0.66 per share.
- 5The dividend payment date is set for December 27, 2024.
- 6The record date for the dividend is December 13, 2024.
- 7The filing includes an embedded interactive data file for easier analysis of financial information.